X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
voglibose (197) 197
index medicus (92) 92
humans (62) 62
inositol - analogs & derivatives (62) 62
male (60) 60
acarbose (59) 59
pharmacology & pharmacy (45) 45
diabetes mellitus, type 2 - drug therapy (38) 38
female (37) 37
middle aged (35) 35
alpha-glucosidase inhibitor (34) 34
endocrinology & metabolism (33) 33
diabetes (32) 32
hypoglycemic agents - therapeutic use (28) 28
glucose (27) 27
adult (26) 26
aged (24) 24
diabetes mellitus (24) 24
inositol - therapeutic use (24) 24
miglitol (24) 24
type 2 diabetes (24) 24
mellitus (23) 23
type 2 diabetes mellitus (23) 23
alpha-glucosidase inhibitors (22) 22
glycoside hydrolase inhibitors (22) 22
metformin (22) 22
diabetes mellitus, type 2 - blood (21) 21
hypoglycemic agents - administration & dosage (21) 21
inositol - pharmacology (21) 21
inositol - administration & dosage (20) 20
animals (19) 19
blood glucose - analysis (18) 18
hypoglycemic agents - pharmacology (18) 18
postprandial hyperglycemia (18) 18
glucagon-like peptide-1 (17) 17
insulin - blood (16) 16
sitagliptin (16) 16
α-glucosidase inhibitor (16) 16
hyperglycemia (15) 15
double-blind (14) 14
insulin (14) 14
mitiglinide (14) 14
obesity (14) 14
postprandial period (14) 14
secretion (14) 14
blood glucose - metabolism (13) 13
cross-over studies (13) 13
medicine & public health (13) 13
dextrose (12) 12
drug therapy, combination (12) 12
efficacy (12) 12
glycemic control (12) 12
hypoglycemic agents - adverse effects (12) 12
inositol - adverse effects (12) 12
nateglinide (12) 12
tolerance (12) 12
valiolamine (12) 12
blood glucose - drug effects (10) 10
enzyme inhibitors - pharmacology (10) 10
hyperglycemia - drug therapy (10) 10
insulin sensitivity (10) 10
rats (10) 10
therapy (10) 10
glibenclamide (9) 9
glycated hemoglobin a - analysis (9) 9
japanese patients (9) 9
medicine, general & internal (9) 9
pharmacokinetics (9) 9
asian continental ancestry group (8) 8
biochemistry & molecular biology (8) 8
drug interactions (8) 8
fixed-dose combination (8) 8
glp-1 (8) 8
mice (8) 8
phenylalanine - analogs & derivatives (8) 8
risk (8) 8
safety (8) 8
treatment outcome (8) 8
type-2 diabetes-mellitus (8) 8
valienamine (8) 8
1-deoxynojirimycin - analogs & derivatives (7) 7
acarbose - therapeutic use (7) 7
administration, oral (7) 7
analysis (7) 7
ao-128 (7) 7
dipeptidyl peptidase-4 inhibitor (7) 7
double-blind method (7) 7
dpp-4 inhibitor (7) 7
drug combinations (7) 7
endocrinology (7) 7
enzyme inhibitors - therapeutic use (7) 7
insulin-resistance (7) 7
internal medicine (7) 7
medicine, research & experimental (7) 7
metabolism (7) 7
niddm (7) 7
original (7) 7
type 2 (7) 7
vildagliptin (7) 7
リボース (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Biochemistry and Nutrition, ISSN 0912-0009, 2017
The gastrointestinal effects of α-glucosidase inhibitors have not been sufficiently investigated. The aim of this study was to determine whether a single dose... 
breath test | voglibose | gastric emptying
Journal Article
Chemical and Pharmaceutical Bulletin, ISSN 0009-2363, 2019, Volume 67, Issue 6, pp. 540 - 545
Fixed-dose combination (FDC) medicines containing two or more active pharmaceutical ingredients (APIs) in a single dosage form have been reported to improve... 
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2018, Volume 41, Issue 7, pp. 1024 - 1033
Acarbose and voglibose are the most widely used diabetes drugs as glycosidase inhibitors. In this study, the use of these two inhibitors significantly... 
Journal Article
Synlett, ISSN 0936-5214, 09/2017, Volume 28, Issue 14, pp. 1807 - 1810
Abstract A novel synthesis of N-substituted 4-​amino-​6-​methyl resorcinols from polysubstituted cyclohexanone was developed. The reaction was performed in an... 
letter | aromatization | amino resorcinol | voglibose | tandem process | carbasugar | CHEMISTRY, ORGANIC
Journal Article
Journal Article
Chinese Journal of New Drugs, ISSN 1003-3734, 02/2017, Volume 26, Issue 4, pp. 443 - 449
Journal Article
Endocrine Journal, ISSN 0918-8959, 2016
This study was designed with the goal of examining the effects of voglibose administration on body weight and lipid metabolism and underlying mechanism high... 
Obesity | Bile acid | Voglibose | Lipid metabolism | Microbiome
Journal Article
Journal of Clinical and Diagnostic Research, ISSN 2249-782X, 08/2015, Volume 9, Issue 8, pp. FC01 - FC03
Prediabetes is an intermediate state between diabetes and normoglycaemia, where the glucose levels are higher than normal but not significant to be diagnosed... 
Voglibose | Normoglycaemia | Metformin | Pharmacology Section
Journal Article
Endocrine Journal, ISSN 0918-8959, 2015
This trial was conducted to compare the efficacy and safety of combination therapy with basal insulin glargine plus mitiglinide to that of basal insulin... 
Mitiglinide | Diabetes mellitus | Type 2 | Voglibose
Journal Article
Journal of Korean Society for Clinical Pharmacology and Therapeutics, ISSN 1225-5467, 06/2013, Volume 21, Issue 1, pp. 63 - 70
Voglibose is an α-glucosidase inhibitor. The purpose of this study was to evaluate the pharmacodynamic characteristics of voglibose for determining the... 
Voglibose | Pharmacodynamic | Diabetes | Equivalence
Journal Article
Journal of Korean Society for Clinical Pharmacology and Therapeutics, ISSN 1225-5467, 06/2013, Volume 21, Issue 1, pp. 34 - 40
Voglibose, an inhibitor of α-glucosidase of the small intestine brush border, is used to treat type 2 diabetic patients. Bioequivalence test based on... 
Voglibose | pharmacodynamics | Therapeutic Equivalency
Journal Article
Journal of Korean Society for Clinical Pharmacology and Therapeutics, ISSN 1225-5467, 2013, Volume 21, Issue 1, pp. 34 - 40
Journal Article
International Journal of Pharmacy and Pharmaceutical Sciences, 2015, Volume 7, Issue 5, pp. 288 - 293
Journal Article
Journal of Korean Society for Clinical Pharmacology and Therapeutics, ISSN 1225-5467, 2013, Volume 21, Issue 1, pp. 63 - 70
Journal Article
Nutritional Neuroscience, ISSN 1028-415X, 03/2018, pp. 1 - 8
The alpha-glucosidase inhibitor voglibose (VO) was recently reported to have a protective effect against weight gain as well as affect various metabolic... 
Voglibose | Metabolomics | ATP/ADP ratio | Hypothalamus | Food intake | 2-Hydroxy-2-methyl-butyric acid
Journal Article
Carbohydrate Research, ISSN 0008-6215, 01/2015, Volume 402, pp. 81 - 86
Journal Article
YAKUGAKU ZASSHI, ISSN 0031-6903, 2016, Volume 136, Issue 8, pp. 1171 - 1176
The aim of this study was to examine the effects of food thickeners on the pharmacodynamics of voglibose, an α-glucosidase inhibitor. The pharmacodynamics of... 
oral-disintegrating tablet | blood sugar elevation | voglibose | food thickener
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 12/2017, Volume 70, Issue 6, pp. 382 - 389
GLP-1 has been reported to be cardioprotective against ischemia-reperfusion injury. We aimed to examine the effect of alogliptin, which may produce GLP-1, on... 
eNOS | nitric oxide | VOGLIBOSE | CARDIAC & CARDIOVASCULAR SYSTEMS | GLP-1 receptor | myocardial infarction | Akt | SYNTHASE | INHIBITION | GLUCAGON-LIKE PEPTIDE-1 | RISK-FACTOR | GLUCOSE | alogliptin | PHARMACOLOGY & PHARMACY | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.